Literature DB >> 2393085

Determination of iodine and bromine in plasma and urine by inductively coupled plasma mass spectrometry.

P Allain1, Y Mauras, C Dougé, L Jaunault, T Delaporte, C Beaugrand.   

Abstract

The simultaneous determination of iodine and bromine in plasma and urine by inductively coupled plasma mass spectrometry, using a Nermag prototype instrument, is described. The sample preparation involves only a 10-fold dilution with a diluent containing europium as an internal standard followed by direct nebulisation in the plasma. The iodine, bromine and europium ions are measured at m/z = 127, 79, and 153, respectively. The sensitivity of the method, with detection limits of 1.6 and 52 micrograms l-1 for iodine and bromine, respectively, is satisfactory for clinical applications. The calibration graphs were linear over the ranges 0-400 micrograms l-1 and 0-40 mg l-1 for iodine and bromine, respectively, which are wide enough for most assays. The recoveries were close to 100% with coefficients of variation of less than 3%. The within-day and between-day reproducibility was about 5%. The concentrations of iodine and bromine in the plasma of 26 healthy individuals were 58 +/- 12 micrograms l-1 and 4.1 +/- 0.9 mg l-1, respectively. The amounts of iodine and bromine eliminated in urine were 94 +/- 97 micrograms per 24 h (range 27-403 micrograms per 24 h) and 3.6 +/- 1.7 mg per 24 h, respectively. These results are in agreement with reported values.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393085     DOI: 10.1039/an9901500813

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  8 in total

1.  Development of Standard Reference Materials to support assessment of iodine status for nutritional and public health purposes.

Authors:  Stephen E Long; Brittany L Catron; Ashley Sp Boggs; Susan Sc Tai; Stephen A Wise
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

2.  Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.

Authors:  G Carayanniotis; G C Huang; L B Nicholson; T Scott; P Allain; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

3.  Bromide and N-acetyl-S-(n-propyl)-L-cysteine in urine from workers exposed to 1-bromopropane solvents from vapor degreasing or adhesive manufacturing.

Authors:  Kevin William Hanley; Martin R Petersen; Kenneth L Cheever; Lian Luo
Journal:  Int Arch Occup Environ Health       Date:  2010-03-14       Impact factor: 3.015

4.  Use of plasma iodine assay for diagnosing thyroid disorders.

Authors:  P Allain; S Berre; N Krari; P Lainé-Cessac; A Le Bouil; N Barbot; V Rohmer; J C Bigorgne
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

5.  Bromine and thyroid hormone activity.

Authors:  P Allain; S Berre; N Krari; P Laine; N Barbot; V Rohmer; J C Bigorgne
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

6.  N-acetyl-S-(n-propyl)-l-cysteine in urine from workers exposed to 1-bromopropane in foam cushion spray adhesives.

Authors:  Kevin W Hanley; Martin R Petersen; Kenneth L Cheever; Lian Luo
Journal:  Ann Occup Hyg       Date:  2009-08-25

7.  Effects of thyroparathyroidectomy on the distribution of bromine and iodine in rat tissues.

Authors:  N Krari; S Berre; P Allain
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

8.  Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter.

Authors:  Juan P Nicola; Nancy Carrasco; L Mario Amzel
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.